Leonardo Drs Inc 's Revenue in the fiscal year 2025 $ 3,648.00 millions
Leonardo Drs Inc 's Revenue in the fiscal year 2024 $ 3,234.00 millions
Leonardo Drs Inc 's Revenue in the fiscal year 2023 $ 2,826.00 millions
Leonardo Drs Inc 's Revenue in the fiscal year 2022 $ 2,693.00 millions
Leonardo Drs Inc 's Revenue in the fiscal year 2021 $ 2,778.00 millions
DRS Revenue second quarter 2026 Y/Y Growth Comment
Leonardo Drs Inc reported Revenue increase of 10.13% year on year in the second quarter 2026, to $ 913.00 millions, this is lower than Leonardo Drs Inc 's recent average Revenue improvement of 20.04%.
Looking into second quarter 2026 results within Aerospace & Defense industry 27 other companies have achieved higher Revenue growth. While Leonardo Drs Inc ' s Revenue growth of 10.13% ranks overall at the positon no. 2396 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Leonardo Drs Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
31.72 %
3.28 %
-30.61 %
(Dec 31 2023)
DRS's II. Quarter Q/Q Revenue Comment
Leonardo Drs Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 7.92%, to $ 913.00 millions, from $846.00 millions in the first quarter. DRS is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Aerospace & Defense industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Leonardo Drs Inc 's Revenue growth quarter on quarter, overall rank is 939.
Leonardo Drs Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 7.92%, to $ 913.00 millions, from $846.00 millions in the first quarter. DRS is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Aerospace & Defense industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Leonardo Drs Inc 's Revenue growth quarter on quarter, overall rank is 939.
Leonardo Drs Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 3,779.00
$ 3,695.00
$ 3,648.00
$ 3,569.00
$ 3,421.00
Y / Y Revenue Growth (TTM)
10.46 %
10.46 %
12.8 %
12.27 %
11.43 %
Year on Year Revenue Growth Overall
Ranking
# 1364
# 1187
# 589
# 687
# 694
Seqeuential Revenue Change (TTM)
2.27 %
1.29 %
2.21 %
4.33 %
2.27 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2396
# 2220
# 1527
# 1670
# 1627
Cumulative Revenue growth Comment
Although Leonardo Drs Inc 's Annual Revenue growth year on year were below company's average 20.04% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 10.46% year on year, from 10.46% in Mar 31 2026.
In the Capital Goods sector 104 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1187 to 1364.
Although Leonardo Drs Inc 's Annual Revenue growth year on year were below company's average 20.04% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 10.46% year on year, from 10.46% in Mar 31 2026.
In the Capital Goods sector 104 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1187 to 1364.
About Leonardo Drs Inc Revenue Growth Rates (DRS), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.